Additional research regarding the mechanism of how FOXC1 affects chemotherapeutic efficacy and FOXC1 is warranted to supply further evidence in selecting appropriate chemotherapeutics for breast cancer patients in clinical settings. Here, FOXC1 is linked to breast cancer.